
Melvin LK CHUA/X
Jun 17, 2025, 06:28
Melvin LK CHUA: Interesting Poll From Nasopharyngeal Carcinoma
Melvin LK CHUA, Clinician-Scientist at the NCCS and Duke-NUS Medical School, shared a post on X:
“Interesting poll from Nasopharyngeal Carcinoma.
Meeting in Guangzhou among Chinese Experte.
What should be the SOC for high-risk NPC trial?
In case translation is needed, option 1 is IC+CRT and option 2 is IC+CRT+Cap.”
More posts featuring Melvin LK CHUA on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 17, 2025, 06:28
Jun 17, 2025, 06:19
Jun 17, 2025, 06:11
Jun 16, 2025, 18:35